Giatromanolaki, A., Koukourakis, M., Pezzella, F., Turley, H., Sivridis, E., Bouros, D., . . . Gatter, K. (2008). Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.

Giatromanolaki, A., M. Koukourakis, F. Pezzella, H. Turley, E. Sivridis, D. Bouros, G. Bougioukas, A. Harris, and K. Gatter. Expression of Prolyl-hydroxylases PHD-1, 2 and 3 and of the Asparagine Hydroxylase FIH in Non-small Cell Lung Cancer Relates to an Activated HIF Pathway. 2008.

Giatromanolaki, A., et al. Expression of Prolyl-hydroxylases PHD-1, 2 and 3 and of the Asparagine Hydroxylase FIH in Non-small Cell Lung Cancer Relates to an Activated HIF Pathway. 2008.